Home Cart Sign in  
Chemical Structure| 1418274-28-8 Chemical Structure| 1418274-28-8

Structure of Cilofexor
CAS No.: 1418274-28-8

Chemical Structure| 1418274-28-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cilofexor is a nonsteroidal FXR agonist. Cilofexor was well tolerated and led to significant improvements in liver biochemistries and markers of cholestasis in patients with primary sclerosing cholangitis in a 12-week study.

Synonyms: GS-9674

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cilofexor

CAS No. :1418274-28-8
Formula : C28H22Cl3N3O5
M.W : 586.85
SMILES Code : O=C(C1=CC(N2CC(O)(C3=CC=C(OCC4=C(C5CC5)ON=C4C6=C(Cl)C=CC=C6Cl)C=C3Cl)C2)=NC=C1)O
Synonyms :
GS-9674
MDL No. :MFCD31731099
InChI Key :KZSKGLFYQAYZCO-UHFFFAOYSA-N
Pubchem ID :71228883

Safety of Cilofexor

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04060147 Primary Sclerosing Cholangitis... More >>|Compensated Cirrhosis Less << PHASE1 TERMINATED 2021-09-02 Arizona Liver Health, Chandler... More >>, Arizona, 85224, United States|California Liver Research Institute, Pasadena, California, 91105, United States|University of California San Francisco, Liver Clinic, San Francisco, California, 94143, United States|Schiff Center for Liver Diseases/University of Miami, Miami, Florida, 33136, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, 30309, United States|Indiana University Health University Hospital, Indianapolis, Indiana, 46202, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, 71105, United States|Minnesota Gastroenterology, PA, Maplewood, Minnesota, 55117, United States|Northwell Health Center for Liver Diseases and Transplantation, Manhasset, New York, 11030, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, 75203, United States|University of Virginia Medical Center, Charlottesville, Virginia, 22908, United States|Bon Secours Richmond Community Hospital, Inc. d/b/a Bon Secours Liver Institute of Richmond, Richmond, Virginia, 23226, United States|VCU Clinical Research Services Unit (CRSU) [Patient Site Address], Richmond, Virginia, 23298, United States|University of Washington at Harborview Medical Center, Seattle, Washington, 98104, United States|Liver Institute Northwest, Seattle, Washington, 98105, United States Less <<
NCT02808312 Nonalcoholic Steatohepatitis (... More >>NASH)|Primary Sclerosing Cholangitis (PSC) Less << PHASE1 COMPLETED 2018-10-16 Miami, Florida, 33014, United ... More >>States|Orlando, Florida, 32809, United States|Knoxville, Tennessee, 37920, United States|San Antonio, Texas, 78215, United States|Auckland, 1640, New Zealand Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.70mL

0.34mL

0.17mL

8.52mL

1.70mL

0.85mL

17.04mL

3.41mL

1.70mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories